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The effects of 5-(N,N-dimethyl)amiloride, a potent and specific Na+-H + 
exchange inhibitor, were investigated in isolated perfused rabbit hearts sub- 
jected to ischemia and reperfusion. Phosphorus 31-nuclear magnetic reso- 
nance spectroscopy was used to monitor intracellular pH, creatine phosphate, 
/]-adenosine triphosphate, and inorganic phosphate. After cardioplegic arrest 
with St. Thomas' Hospital solution, normothermic (37 ° C) global ischemia was 
induced for 45 minutes, and the hearts were reperfused for 50 minutes. 
Dimethyl amiloride at 10/xmol/L, which has minimal inotropic and chrono- 
tropic effects on the nonischemic heart, was added to the cardioplegic solution. 
Treatment with dimethyl amiloride reduced the elevation of left ventricular 
end-diastolic pressure during and after the ischemia and improved the 
postischemic recovery of developed pressure from 76% -+ 3.2% at 30 minutes 
of reperfusion i  control hearts (n = 6) up to 99% + 1.9% in hearts treated 
with dimethyl amiloride (n -- 8). Dimethyl amiloride did not affect he decline 
in intracellular pH during ischemia for up to 30 minutes but enhanced the 
intracellular acidosis thereafter. The intracellniar pH at the end of ischemia 
was 6.21 - 0.05 in control hearts compared with 5.24 - 0.17 in hearts treated 
with dimethyl amiloride (p < 0.05). During reperfusion, intracellular pH of 
hearts treated with dimethyl amiloride was less than control for 5 minutes, but 
subsequent recovery of intracellular pH was similar to control. Treatment with 
dimethyl amiloride did not affect creatine phosphate breakdown, inorganic 
phosphate accumulation, and l~-adenosine triphosphate depletion during 45 
minutes of ischemia. The creatine phosphate resynthesis and inorganic 
phosphate reduction during reperfusion were also unaffected. These findings 
suggest hat Na+-H + exchange plays an important role not only during 
reperfusion but also during ischemia for the development of postischemic 
cardiac dysfunction most likely by inducing primary Na + and secondary Ca 2+ 
overload. Specific Na+IH + exchange inhibitors like dimethyl amiloride would 
have a potential therapeutic profile in cardiac surgery, especially if added 
before ischemia. (J Thorac Cardiovasc Surg 1996;112:765-75) 
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p harmacologic evidence for the involvement of 
sarcolemmal Na+-H + exchange in myocardial 
ischemia-reperfusion njury has emerged from many 
experimental studies showing various salutary ef- 
fects of Na+-H + exchange inhibitors, including 
amiloride and other organic compounds. 1-3 In ani- 
mal experiments in which rats, guinea pigs, rabbits, 
and dogs were used, many investigators have dem- 
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onstrated that treatment of hearts with amiloride or 
other compounds having more specific inhibitory 
action against Na+-H + exchange improves postisch- 
emic contractile recovery, 4-7 reduces reperfusion 
arrhythmias, s diminishes creatine kinase effiux dur- 
ing reperfusion, 6 preserves microscopic ellular in- 
tegrity, 9 or reduces Na +~ and Ca 2+i accumula- 
tion.4, 10 Regarding the precise nature of their 
beneficial effects, however, several issues remain to 
be resolved. 
Controversy exists as to whether cardiac protec- 
tion by Na+-H ÷ exchange inhibitors is limited to 
reperfusion or would also occur under ischemic 
conditions. 2'3 Na÷-H + exchange inhibitors were 
shown to have a certain protective effect if the 
compound was given only during reperfusion. 6-9 
Nevertheless, protection is also present during isch- 
emia 9,11,12 and is even more pronounced if the 
inhibitor is given during ischemia nd reperfusion. 9 
The protective ffects of Na+-H + exchange inhibi- 
tors were associated with the preservation of high- 
energy phosphates in some studies, 9'13 but not in 
others.4, 10 
The cardioprotective effects of Na +-H + exchange 
inhibitors have the potential to be clinically useful. 
In view of the preclinical data, the most promising 
indications for the inhibitors include the typical 
ischemia-reperfusion situation, in which the start of 
ischemia and reperfusion is known and sufficient 
concentrations of the compound can be applied to 
the heart. This is the case in cardiac surgery. 3 
During cardiac operations, the contraction of the 
heart has to be stopped by a cardioplegic solution. 
The heart is disconnected from systemic blood flow 
and is reperfused at the end of the procedure. 
Various protective drugs are, therefore, usually ap- 
plied to the cardioplegic solution so that their 
concentration i the heart will remain high enough 
without affecting other organs. To our knowledge, 
however, little information is available as to the 
cardioprotective effects of Na+-H + exchange inhib- 
itors against ischemia-reperfusion injury when ap- 
plied to the cardioplegic solution. 
The current study was designed to gain further 
insight into the mechanism of cardioprotective ac- 
tion of Na+-H + exchange inhibitors and their po- 
tential therapeutic profile in cardiac surgery. We 
investigated the effects of 5-(N,N-dimethyl) amilo- 
ride (DMA), a more potent and more specific 
inhibitor of Na+-H + exchange than amiloride, &14 
on the sequential changes of left ventricular contrac- 
tility, intracellular pH (pHi), and high-energy phos- 
phates in isolated perfused rabbit hearts subjected 
to normothermic global ischemia during cardiople- 
gic arrest and subsequent reperfusion. DMA was 
applied to the cardioplegic solution, and pHi and 
energy metabolism were monitored by use of phos- 
phorus 31-nuclear magnetic resonance (NMR) 
spectroscopy. 
Materials and methods 
Preparation. Hearts were obtained from young white 
rabbits, 4 to 7 weeks old, weighing 500 to 800 gm. After 
intravenous administration of heparin (1000 IU) and 
thiamylal sodium (20 mg/kg), hearts were quickly excised 
and placed in cold (4 ° C) perfusion solution. The aorta 
was cannulated for nonrecirculating Langendorff perfu- 
sion at a constant hydrostatic pressure (75 cm H20). The 
control perfusate was a modified phosphate-flee Krebs- 
Henseleit bicarbonate buffer solution of the following 
composition (in millimoles per liter): NaC1, 118; KC1, 5.9; 
NaHCO3, 25; MgSO4, 1.2; CaC12, 2.5; and glucose, 5.5. 
The solution was equilibrated with 95% oxygen and 5% 
carbon dioxide to achieve a pH of 7.4 at 37 ° C. A latex 
balloon (size 4.3 mm in maximal diameter and 6.3 mm in 
length, Hirokawa, Niigata, Japan) was introduced into the 
left ventricle via the left atrium and connected to a 
strain-gauge transducer (MIP-5100, Baxter, Tokyo, Ja- 
pan) for measurement of isovolumic left ventricular pres- 
sure. The balloon was filled with distilled water containing 
a 0.5 mol/L concentration f methylene diphosphonic a id 
as external standard of the NMR spectral reference. The 
left ventricular end-diastolic pressure was adjusted to 5 
mm Hg during the equilibration period in each heart, and 
the volume was unchanged uring the experiments. The 
left ventricular developed pressure was calculated by 
subtracting left ventricular end-diastolic pressure from left 
ventricular systolic pressure. The maximum rate of con- 
traction and relaxation (+dp/dt) was obtained by elec- 
tronic differentiation. The pulmonary artery was incised to 
ensure adequate right ventricular venting. Myocardial 
temperature was maintained at 37 ° -+ 0.5 ° C by a water- 
jacketed perfusion line and a continuous tream of air 
around the sample tube of NMR. 
All animals have received humane care in compliance 
with the "Principles of Laboratory Animal Care" formu- 
lated by the National Society for Medical Research and 
the "Guide for the Care and Use of Laboratory Animals" 
prepared by the Institute of Laboratory Animal Resources 
and published by the National Institutes of Health (NIH 
publication No. 86-23, revised 1985). 
NMR spectroscopy. In all the ischemia-reperfusion ex- 
periments, 31P-NMR spectra were monitored along with 
simultaneous recording of ventricular pressure. The heart 
connected tothe Langendorff perfusion line was placed in 
a standard 20 mm NMR tube with the apex approximately 
2.5 cm from the bottom of the tube, and the tube was 
inserted into the NMR coil. The effluent was removed 
from a level above the heart by a peristaltic pump, leaving 
the heart submerged in a fixed volume of the perfusate. 
31P-NMR spectra were obtained at 161.8 MHz on a 
GSX 400 spectrometer (Jeol Datum Co. Ltd., Tokyo, 
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Fig. 1. 31p-NMR spectra obtained from an untreated (control) rabbit heart before ischemia, during 
ischemia, and during reperfusion. Numbered peaks are as follows: 1, methylene diphosphate; 2, 
intracellular Pi; 3, PCr; 4, 5, and 6, 3'-, c~-, and/3-phosphate group of ATP, respectively. 
Japan) equipped with a 9.4-tesla vertical-bore magnet. 
For each spectrum, 90 free-induction decays (4 minutes) 
were accumulated after 45-degree flip-angle pulses (18 
ptsec) by use of 4096 data points and 15.015 kHz spectral 
width at a repetition time of 2 seconds. Accumulated 
free-induction decays were exponentially filtered, result- 
ing in 30 Hz line broadening. Quantification of inorganic 
phosphate (Pi), phosphocreatine (PCr), and/3-adenosine 
triphosphate (ATP) in the myocardium was achieved by 
integration of areas under individual peaks of interest in 
each spectrum using a specially designed gaussian line 
fitting software (Datum Station ALICE, Jeol Datum) 
installed in a computer (NEC 9801, NEC Co., Ltd., 
Tokyo, Japan). 15 Values of PCr and ATP were expressed 
as a percentage relative to the individual spectrum ob- 
tained during the preischemic ontrol period. Pi was 
expressed as a percentage of the sum of phosphate from 
PCr, ATP, and Pi during preischemic control perfusion a6 
by the equation: (Pi/[PCr + 3ATP + Pi]prcischemic ) × 
100%. 
pH~ was measured by the chemical shift of the Pi peak 
relative to the PCr peak. The chemical shift values in parts 
per million were converted to pH units as previously 
described17, is (Fig. 1). 
Protocols 
Effects of DMA on mechanical performance of nonisch- 
emic hearts. Hearts were allowed to beat spontaneously 
with a rate ranging from 147 to 174 beats/min. After a 
stabilization period of 20 to 30 minutes, the perfusate was 
changed from the control to a solution including DMA at 
a concentration of 10 p~mol/L. Effects of DMA on heart 
rate, left ventricular systolic, end-diastolic, and developed 
pressure, +dp/dt, and -dp/dt were monitored uring 45 
minutes of exposure to DMA and 30 minutes after the 
compound was washed out. 
Influence of DMA on the hearts ubjected to ischemia nd 
reperfusion. After a stabilization period in the test tube 
of the NMR spectrometer for 20 to 30 minutes, pre- 
ischemic values for left ventricular systolic, end-dia- 
stolic, and developed pressures, -+dp/dt, and heart rate 
were recorded. The hearts were then perfused with St. 
Thomas' Hospital cardioplegic solution at 37°C at a 
constant pressure (75 cm H20). The composition of the 
solution was as follows (in millimoles per liter): NaC1, 
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Fig. 2. Changes in the left ventricular end-diastolic pressure (LVEDP) during 45 minutes of ischemia nd 
subsequent 50 minutes of reperfusion. Left ventricular end-diastolic pressure is plotted as a function of 
time. Zero time is the beginning of cardioplegia and the beginning of reperfusion. Values are presented in 
means -+ standard error of six untreated hearts (control, open circles) and eight hearts treated with DMA 
at 10/xmol/L (closed circles). *Significantly different from control at p < 0.05. 
110; KC1, 16; MgC12, 16; CaC12, 1.2, and NaHCO 3, 10.0 
(pH 7.8). DMA was added to the St. Thomas' Hospital 
cardioplegic solution at 10 /xmol/L. The cardioplegia 
line was then clamped and global ischemia was pro- 
duced for 45 minutes at normothermia (37 ° C). The 
hearts were bathed in the cardioplegic solution to avoid 
oxygen diffusion from the surrounding air. After isch- 
emia, the hearts were reperfused with the control 
perfusate at 37 ° C for 50 minutes. During the ischemia- 
reperfusion insult, hemodynamic measurements were 
repeated to document functional deterioration and 
recovery. The hearts were allowed to beat spontane- 
ously throughout the experiments. 
Effects of DMA on hearts subjected to isehemia and 
reperfusion. Fourteen hearts subjected to normothermic 
cardioplegic arrest plus ischemia and reperfusion were 
divided into two groups. In six control hearts, normal St. 
Thomas' Hospital cardioplegic solution was used for 
cardioplegia before ischemia. In the remaining eight 
hearts, DMA was added to the cardioplegic solution in a 
concentration of 10 ~mol/L. 
Data analysis. All the data were presented as 
means +_ standard error unless otherwise specified. 
Hemodynamic data in experiments with nonischemic 
hearts were expressed as a percentage of pre-drug 
control values. In ischemia-reperfusion experiments, 
preischemic function was expressed as an absolute 
value for each parameter. Postischemic recovery of 
cardiac function was expressed as an absolute value and 
as a percentage of its preischemic level. We analyzed 
NMR data from 15 minutes before ischemia to up to 30 
minutes of reperfusion because of a limitation of sam- 
pling and processing capacity of our computer system, 
and because hemodynamic recovery of both control and 
DMA-treated hearts reached almost plateau levels at 
30 minutes of reperfusion (Figs. 2 and 3). The unpaired 
t test was used for comparison of means between the 
groups. Statistical significance was defined as p < 0.05. 
Results 
Effects of DMA on left ventricular contractility in 
nonischemic hearts. Treatment  of  the hearts with 
DMA at 10/xmol/L resulted in a gradual decrease 
in heart rate. Heart  rate at the end of 45 minutes'  
exposure to DMA reached 67% +- 10.0% of the 
control  level (n = 5 ,p  < 0.05). Average values of 
left ventr icular systolic and developed pressures, 
+dp/dt,  and -dp /dt  were virtually unaffected 
by the DMA treatment.  On washing out of DMA 
for 30 minutes, heart  rate recovered to 86% -+ 
6.7% of control  (p < 0.05). No appreciable 
changes in left ventr icular end-diastol ic pressure 
occurred throughout  the exposure and washing 
out of  DMA.  
Hemodynamic function. Averages of heart rate, 
left ventricular systolic and developed pressures, 
+dp/dt, and -dp /dt  under preischemic ondition 
are summarized in Table I. No significant differ- 
ences were observed in these baseline parameters 
between the control and DMA-treated groups. 
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Fig. 3. Changes in the left ventricular systolic pressure (LVSP), developed pressure (LVDP), and 
maximum rate of contraction and relaxation (+_dp/dt) during 45 minutes of ischemia nd a subsequent 50 
minutes of reperfusion. The hemodynamic parameters are plotted as a function of time. Zero time is the 
beginning of cardioplegia nd the beginning of reperfusion. Values are means _+ standard error of six 
untreated hearts (control, open circles) and of eight hearts treated with DMA at 10/zmol/L (closed circles). 
*Significantly different from control at p < 0.05. 
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Table I. Baseline hemodynamic parameters during 
the preischemic condition 
Control group DMA group 
(n = 6) (n = 8) 
HR (beats/min) 168 -+ 3.3 157 _+ 3.1 
LVDP (mm Hg) 72 -+ 2.6 68 -+ 6.0 
LVSP (mm Hg) 77 _+ 2.6 63 +_ 6.0 
+alp/tit (mm Hg/scc) 1800 +_ 67 1790 _+ 64 
-dp/dt  (ram Hg/sec) 1330 -+ 79 1480 _+ 53 
HR, Heart rate; DMA, dimethyl amiloride; LVDP, left ventricular devel- 
oped pressure; LVSP, left ventricular systolic pressure. There was no 
significant difference between the groups. Values are means _+ standard 
error of the mean. 
Sequential changes in left ventricular end-dia- 
stolic pressure during and after ischemia re shown 
in Fig. 2. In the control group (n = 6), left ventric- 
ular end-diastolic pressure increased progressively 
during the 45-minute period of ischemia. When the 
hearts were reperfused, end-diastolic pressure fur- 
ther increased temporarily, giving rise to a peak at 1 
minute of reperfusion. Pressure then decayed rather 
quickly toward the preischemic level within 20 min- 
utes. Left ventricular end-diastolic pressure in the 
DMA-treated hearts (n = 8) also increased uring 
and immediately after ischemia with a similar time 
course, but the extent of increase was significantly 
less than control. 
Fig. 3 summarizes the changes in left ventricular 
systolic and developed pressures and _+dp/dt during 
and after ischemia. In both control and DMA- 
treated hearts, left ventricular systolic and devel- 
oped pressures decreased rapidly after initiation of 
cardioplegia, and the mechanical contraction be- 
came undetectable within 1 minute. On reperfusion, 
left ventricular systolic and developed pressures 
showed dual phases of recovery; initial rapid recov- 
ery within 5 minutes was followed by much slower 
recovery thereafter. In the control group(n = 6), 
the initial rapid recovery of left ventricular systolic 
and developed pressures after ischemia peaked at 3 
minutes of reperfusion. Then left ventricular systolic 
and developed pressures decayed a little before the 
subsequent slower recovery. At 30 minutes of reper- 
fusion, they reached aplateau at 82.4% - 5.4% and 
75.6% -+ 3.2%, respectively. In the DMA-treated 
group (n = 8), recovery of left ventricular systolic 
and developed pressures during reperfusion was 
slower during the initial 5 minutes, but it was 
significantly greater during the subsequent period, 
reaching 99.5% _+ 1.7% and 99.9% _+ 1.9% of their 
respective preischemic levels at 30 minutes of reper- 
fusion (p < 0.05 vs control). During reperfusion 
later than 30 minutes, left ventricular systolic and 
developed pressures further increased, and at 50 
minutes they reached 5% to 11% above their pre- 
ischemic levels. 
Comparative differences between control and 
DMA-treated hearts were observed in the recovery 
of _+ dp/dt. At 5 minutes of reperfusion, recovery of 
+dp/dt and -alp/tit in the DMA-treated group 
toward the baseline was significantly less than that of 
the control group. At 30 minutes' reperfusion, how- 
ever, the recovery of +dp/dt and -dp/dt in the 
DMA-treated group was significantly higher than in 
the control group. 
In both the control and DMA-treated hearts, 
heart rate recovered nearly completely by 10 min- 
utes of reperfusion, and there was no significant 
difference between the two groups. 
pH i. Changes in pH i during and after ischemia 
are shown in Fig. 4. The initial (preischemic) level of 
pH i was almost identical in control (7.25 + 0.04, n = 
6) and DMA-treated hearts (7.26 _+ 0.05, n = 8). An 
infusion of St. Thomas' Hospital solution resulted in 
a transient increase in pH i in both control (up to 
7.56 _+ 0.05) and DMA-treated hearts (up to 7.67 _+ 
0.08), probably because of the higher pH (7.8) of the 
cardioplegic solution and PCr breakdown (see Dis- 
cussion). 
During the subsequent period of ischemia, pH~ 
decreased progressively; its reduction was similar in 
both groups for 30 minutes of ischemia, but signifi- 
cantly greater in the DMA-treated group than i  the 
control group thereafter. The pH i at the end of 45 
minutes of ischemia was 6.21 _ 0.05 in control 
hearts and 5.24 _+ 0.17 in the DMA-treated hearts. 
During reperfusion, pH i in both control and DMA- 
treated hearts increased rapidly and returned to the 
preischemic level within 15 minutes. For the first 5 
minutes of reperfusion, pH i of the DMA-treated 
hearts was lower than control, but there was no 
significant difference in the levels during the subse- 
quent period of reperfusion. 
High-energy phosphates. Changes in PCr, Pi, and 
ATP levels during and after 45 minutes of ischemia 
are shown in Fig. 5. PCr and ATP values are 
presented as percentages relative to the preischemic 
baseline, whereas Pi values are expressed as per- 
centages of the sum of phosphates during the pre- 
ischemic period. 16 During isehemia, the rapid eg- 
radation of PCr was balanced by an increase in 
intracellular Pi. A moderate decrease in ATP was 
observed as well. 
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On reperfusion, PCr was rapidly resynthesized to 
levels above the preischemic baseline in both control 
and DMA-treated groups. In association with this 
change in PCr, Pi decreased rapidly to the preisch- 
emic baseline. In contrast, there was no appreciable 
change in ATP levels during the 30-minute r perfu- 
sion period, and there were no significant differ- 
ences between control and DMA-treated groups in 
these sequential changes of high-energy phosphates 
during and after ischemia. 
Discussion 
DMA. In the present study we used DMA as a 
pharmacologic tool to inhibit Na+-H + exchange in 
cardiac cell membrane, because of its high potency 
and high specificity. DMA is 10 to 24 times more 
potent than amiloride in inhibition of Na+-H + 
exchange, but it is less effective than amiloride in 
other intrinsic actions unrelated to the antiport. 8'14 
The dose of DMA used in our experiments (10 
/xmol/L) is close to the 50% inhibitory concentration 
for DMA to block Na+-H + exchange in sarcolem- 
mal vesicles, but much less than the 50% inhibitory 
concentration to block Na+-Ca 2+ exchange (550 
txmol/L), Na/K ATPase (3000 /xmol/L), voltage- 
gated Na + channel (>50 /xmol/L), and voltage- 
gated Ca 2+ channel (>50 /zmol/L). 8' 14 DMA also 
has an advantage over other amiloride analogs in 
terms of its specificity. 15 
We did not pace the hearts at a constant rate for 
the sake of simplicity of equipment around the 
NMR tube. instead, the hearts were allowed to beat 
spontaneously throughout each ischemia-reperfu- 
sion experiment. This may not invalidate the effects 
of DMA, because spontaneous beating was termi- 
nated by cardioplegia t the onset of ischemia, and 
there was no significant difference in heart rate 
between control and DMA-treated groups during 
the entire period of reperfusion. 
The protective actions of DMA against ischemia- 
reperfusion damage to contractility in the present 
experiments are qualitatively similar to those re- 
ported by Meng and associates. 6,z°' al In experi- 
ments using coronary-perfused rat ventricular mus- 
cles, they showed that treatment of the preparations 
with DMA (1 to 20 /xmol/L) before 60 minutes of 
ischemia nd at the time of reperfusion reduced the 
elevation of the resting tension and improved the 
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period. Values are means _+ standard error of the mean of six untreated hearts (control, open circles) and 
eight hearts treated with DMA at 10/xmol/L (closed circles). 
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recovery of contractility in a concentration-depen- 
dent manner. DMA (10 to 50 /xmol/L) was also 
reported to reduce reperfusion arrhythmias s and to 
reduce the intracellular Ca 2+ accumulation during 
ischemia in rat hearts. 1° To our knowledge, how- 
ever, this is the first report to demonstrate hat 
DMA, when added to cardioplegic solution, protects 
against ischemia-reperfusion njury in mammalian 
hearts at a concentration with minimal intrinsic 
actions. 
phi. The pH i at the beginning of ischemia (im- 
mediately after infusion of St. Thomas' Hospital 
cardioplegic solution) increased slightly both in con- 
trol hearts (from 7.25 to 7.57) and in DMA-treated 
hearts (from 7.26 to 7.67). This transient alkalosis 
may be attributed inpart to the higher pH level (7.8) 
of the cardioplegic solution. A rapid breakdown of 
PCr, which absorbs H +, in the initial period of 
ischemia (see Fig. 5) may also help to produce this 
transient alkalosis because it increases intracellular 
H ÷ buffering capacity. 1 pH i then decreased progres- 
sively during the subsequent period of ischemia. 
DMA treatment did not affect his pH i reduction for 
the initial 30 minutes, but it enhanced the intracel- 
lular acidosis during the later period of ischemia. At 
the end of the 45-minute period of ischemia in the 
DMA-treated hearts, pHi (5.24) was 1.0 unit lower 
than in control hearts; it recovered rapidly in both 
control and DMA-treated hearts and returned to 
the preischemic level by 10 to 15 minutes. In the 
DMA-treated group during reperfusion, pHi was 
lower than control only at the initial sampling (4 
minutes). These findings differ from those of previ- 
ous reports on the effects of pharmacologic block of 
Na+-H + exchange on pH i during ischemia-reperfu- 
sion injury. 
In 31p-NMR studies using hearts from rats and 
ferrets, preischemic treatment with amiloride or 
5-(N-ethyl-N-isopropyl)amiloride (EIPA) was 
shown to delay pHi recovery during early reperfu- 
sion without affecting the progressive pH i decline 
during the preceding period of ischemia. 5' 13 Hen- 
drikx and associates 9 also demonstrated in rabbit 
hearts that HOE 694 (a new specific Na+-H + ex- 
change inhibitor) did not affect the pH i decline 
during ischemia, but eliminated the alkaline over- 
shoot at the onset of reperfusion. 
The discrepancy between these previous reports 
and our data may be related to complex regulatory 
mechanisms of intracellular H + concentration. Dur- 
ing ischemia, H + is produced in the cytosol mainly 
from glycolytic ATP turnover, carbon dioxide reten- 
tion, and later net ATP degradation. 1 In the initial 
period of ischemia, protons are first buffered by 
intracellular protein histidine residues and by Pi, 
which is a product of PCr breakdown to help 
maintain ATP levels. Unbuffered intracellular H÷ 
can leave via sarcolemmal H+-lactate cotransporter, 
Na÷-H + exchange, and Na+-HCO3 - coin flux. 1' 22 As 
ischemia progresses, however, further H + etttux is 
likely to be opposed by interstitial H+ accumulation, 
leading to a decrease of transsarcolemmal H +gra- 
dient, and by intracellular Na ÷ accumulation, 
caused by an inhibition of sarcolemmal Na/K 
ATPase. 3 Competition of H ÷ and Ca 2+ in the 
intracellular binding sites 23 also affects the free H + 
concentration in the cytosol. Accumulation of intra- 
cellular Ca 2÷ during ischemia thus favors a further 
decrease in pH i through displacement of H ÷ from 
intracellular buffering sites by Ca 2÷. An active 
Na÷-H + exchange process is not necessarily related 
to pH regulation, because coupling of this process 
with CI--HCO 3 exchange (C1- influx) results in 
zero acid extrusion, and net NaC1 influx, reported to 
be a mechanism for volume regulation. 24' 25 A de- 
crease of H + influx via Na+-H + exchange was 
reported to reduce the H ÷ production by anaerobic 
glycolysis.ll, 26 The ultimate ffect of pharmacologic 
inhibition of Na+-H + exchange on phi, therefore, 
depends on the relative importance of this antiport 
in the total capacity of H ÷ buffering and extrusion 
and on the secondary modulation of intracellular 
H ÷ generation. 
The activity of Na+-H + exchange is known to be 
inhibited by lowering the extracellular pH. 27' 28 The 
pH of the cardioplegic solution used in the present 
study (7.8) is higher than that of ordinary buffer 
perfusates (7.4) used by other investigators. This 
might have helped to maintain greater Na+-H + 
exchange activity during ischemia in our experi- 
ments. Other conditions that increase the Na+-H + 
exchange activity, such as sufficient ranssarcolem- 
real Na + gradient or phosphorylation of the ex- 
changer via protein kinase C, might have been 
different between the present experiments and the 
previous studies. 2 If the relative contribution Gf 
Na+-H + exchange to the net H + buffering and 
extrusion capacity of cardiac muscle is small, an 
inhibition of the antiport will be easily masked by 
other multiple regulatory mechanism as described 
earlier and will result in no observable change in 
pHi. 
On reperfusion, a prompt washout of extracellu- 
lar H ÷ and metabolites is thought to lead to a rapid 
efflux of accumulated intracellular H÷ through a 
passive fflux of lactate and carbon dioxide, as well 
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as an active H + extrusion mechanism (Na+-H + 
exchange and Na÷-HCO3 coinflux). 3'22 In the 
present experiments, treatment with DMA caused 
only a slight delay in pHi recovery during reperfu- 
sion, suggesting a relatively small contribution of 
Nan-H ÷ exchange to the pHi recovery during reper- 
fusion. In a recent extensive study using ferret 
hearts, Vandenberg, Metcalfe, and Grace 22 have 
concluded that the pHi recovery during reperfusion 
is principally mediated by metabolite washout, that 
is, lactate and carbon dioxide extrusion, and that 
Nan-H + exchange and HCO3- influx may contribute 
as much as 20% to 35% of net H ÷ etItux. 
During ischemia, the exchanger is partially inhib- 
ited by low extracellular pH, 27' as but this inhibition 
can be overdriven by intracellular acidosis. 2s A rise 
in intracellular Na ÷ during ischemia nd its suppres- 
sion by amiloride or EIPA have been documented 
by 23Na-NMR.l°' 13 A rise in cytosolic Ca 2+ during 
ischemia nd its suppression by amiloride were also 
demonstrated in 19F-NMR. 1° The present data in- 
dicating an enhancement of pHi reduction and an 
attenuation f left ventricular end-diastolic pressure 
elevation in DMA-treated hearts from the later 
period of ischemia to early reperfusion are in agree- 
ment with those of previous reports suggesting an 
important role of Nan-H + exchange during isch- 
emia. Na+-H ÷ exchange blockers may improve the 
functional recovery of cardiac muscle by limiting the 
Na ÷ gain during ischemia and by inhibiting the 
additional rise of Na÷i on reperfusion when the 
partial block of external acidification on Nan-H + 
exchange is suddenly relieved. Intracellular acidifi- 
cation during the early period of reperfusion would 
also favor the cardiac muscle by inhibition of Ca 2÷ 
entry via Na+-Ca 2÷ exchange, coupling of Ca 2÷ to 
contractile lements, and other Ca2+-induced reac- 
tions. 3
High-energy phosphates. There is considerable 
controversy among previous reports whether the 
protective ffects of Na+-H ÷ exchange blockers are 
associated with an improvement of energy metabo- 
lism. In experiments u ing rat hearts, some investi- 
gators showed that amiloride had no significant 
effects on the reduction of ATP and PCr during 
ischemia and reperfusion. 4' 10 In experiments by 
other investigators using rat or rabbit hearts, 9'13 
however, EIPA or HOE 694 was shown to reduce 
ATP depletion during ischemia and to improve 
recovery of PCr and ATP during reperfusion. In the 
present experiments, preischemic treatment with 
DMA did not affect PCr breakdown, Pi accumula- 
tion, or ATP depletion during 45 minutes of isch- 
emia. The PCr resynthesis and Pi reduction during 
reperfusion were unaffected as well. 
The reason for the different observations i  un- 
clear. Depletion of high-energy phosphates during 
ischemia nd reperfusion could be ameliorated by 
an inhibition of Na+-H + exchange via a reduction of 
intracellular Na n and Ca 2÷ overload, 2' 3 because a
great deal of ATP is used for extrusion of Na n and 
for storage of Ca 2+ in the sarcoplasmic reticulum. 
Ca 2+ overload also activates ATP use by many 
ATPases and inhibits mitochondrial oxidative phos- 
phorylation to produce ATP. 29' 3o The increase of 
left ventricular end-diastolic pressure, which reflects 
Ca 2÷ overload, and the decrease inATP observed in 
our control experiments ofischemia nd reperfusion 
are appreciably less than those reported by Hen- 
drikx, 9 Pik@ 3 and their associates. This is probably 
due to the cardioprotective action of St. Thomas' 
Hospital cardioplegic solution in our experiments. 
Beneficial effects of Na+-H + inhibition on the en- 
ergy metabolism ight be detected only when the 
Na + and Ca a+ overload is above a certain critical 
level. This issue remains to be tested. 
Conclus ion 
The present study has revealed that an applica- 
tion of DMA at an appropriate concentration to
cardioplegic solution at the onset of ischemia causes 
a good improvement of ventricular function during 
the subsequent period of reperfusion. This benefi- 
cial effect is associated with an enhancement of pHi 
reduction during late ischemia nd early reperfusion 
but no appreciable modification of energy metabo- 
lism. It is suggested that Na+-H ÷ exchange plays an 
important role not only during reperfusion but also 
during ischemia for the development of postisch- 
emic cardiac dysfunction, most likely by inducing 
intracellular Na n and Ca 2÷ overload. 
DMA seems to have an interesting therapeutic 
potential in cardiac surgery to ameliorate postarrest 
cardiac dysfunction or postisehemic myocardial 
stunning. More extensive experimental studies, how- 
ever, will have to be carried out before the exact 
clinical usefulness of this compound can be dis- 
cussed. For instance, in cardiac operations inhuman 
beings, unlike the present in vitro experiments, the 
hearts are reperfused with blood. Many experimen- 
tal and clinical studies have shown that Na÷-H ÷ 
exchange plays important roles in activation of 
platelets and neutrophils, which are known to re- 
lease various cardiotoxic factors on reperfusion such 
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as arachidonic acid, thromboxane Az, and leuko- 
triene B4 .2 If these processes are inhibited by DMA, 
its beneficial effects against ischemia-reperfusion 
injury would be amplified. DMA might also modu- 
late the volume regulation process 24' 25 of blood 
cells and cardiac ells by inhibiting Na+-H + ex- 
change. These aspects of the drug action remain to 
be elucidated. 
We thank Makoto Naruse (Aichi Medical University) 
for his technical assistance in the conduct of these exper- 
iments. 
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